MedTrace Logo

Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy

NCT04055870 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2021-06-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC).

Conditions

Interventions

PROCEDURE

EUS-guided liver biopsy at MDMC

Endoscopic ultrasound (EUS) guided liver biopsy sampling is emerging as an alternative to the aforementioned approaches that offers several advantages, including decreased sampling variability and procedure-related complications.

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Prashant Kedia, MD · The Methodist Hospital Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-21
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04055870 on ClinicalTrials.gov